FDA Drug recall D-1471-2014
Tobramycin 300 mg/7.5 mL Syringe (for Neb), Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx…
- FDA Drug
- Class II
- ongoing
- Published 2014-07-30
On 2014-07-30 the FDA classified a Class II recall of Tobramycin 300 mg/7.5 mL Syringe (for Neb), Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx… by Franck S Lab, citing lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associat….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1471-2014 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2014-05-15 |
| Published | 2014-07-30 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Franck S Lab |
| Distribution | FL |
Product
Tobramycin 300 mg/7.5 mL Syringe (for Neb), Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 28503, Discard After 02/27/14
Reason
Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.
Identifiers
| code_info | Rx # 28503, Exp 02/27/14 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1471-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.